account_id none on file
legal_name Barinthus Biotherapeutics plc.
ticker BRNS
cik 1828185
domain barinthusbio.com
linkedin_company_url https://www.linkedin.com/company/barinthusbiotherapeutics/
entry_point_account_id none on file
name Barinthus Biotherapeutics plc
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 3 executives 2 family 0
why_nownone on file
callsnone on file
filings
The Company occupies laboratory and office space in Germantown, Maryland, United States. The Company operates in an environment of rapid technological change and substantial competition from pharmaceutical and biotechnology companies.
filing / Aug 6, 2026 / receipt
The Company leases certain laboratory and office space under operating leases, which are described below. The Harwell Science and Innovation Campus, Oxfordshire On September 3, 2021, the Company entered into a lease agreement for the lease of approximately 31,000 square feet in Harwell, Oxfordshire which expires in September 2031.
filing / Aug 6, 2026 / receipt
This process, which is commonly referred to as “householding,” potentially means extra convenience for shareholders and cost savings for companies.
filing / Jun 10, 2026 / receipt
executives
| Douglas Swirsky | Chief Financial Officer | - | receipt |
| Gemma Brown | Chief Financial Officer | - | receipt |
familynone on file
upcomingnone on file
changes
| 2026-04-22 | Chief Financial Officer, appointed | sec_8k |
| 2022-09-30 | Chief Financial Officer, appointed | sec_8k |
| 2022-09-20 | Chief Financial Officer, appointed | sec_8k |
mcp_package_hint
slug barinthus-biotherapeutics-plc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$